Risk factors associated with mortality in the infective endocarditis patients requiring cardiac surgery: a study based on Latvian population.

BACKGROUND Increased life expectancy, developments in medicine and intracardiac devices, accessibility of cardiac surgery, decrease in the prevalence of rheumatic heart disease are changing infective endocarditis patient profile and thus risk factors for the adverse events. This single-center-based study covering the whole Latvian population aimed to assess the intrahospital and 3-year mortality of infective endocarditis patients who underwent cardiac surgery, as well risk factors and laboratory indices predictive of adverse outcomes of the disease. METHODS Clinical profiles, data of laboratory and instrumental analyses, operation and intensive care unit records of cardiac surgery patients treated in Pauls Stradins Clinical University Hospital, Riga, Latvia between 2015 and 2019 were analysed. RESULTS We analysed data from 242 episodes of surgically treated infective endocarditis in 233 patients. The median age of patients was 57.00 (45.00-68.00) years. The rate of intrahospital mortality was 11.16%. Risk factors associated with mortality in the univariate analyses were S.aureus infection (HR 2.27, 95% CI 1.36-3.80; p=0.002) and systemic embolization of vegetations (HR 1.63, 95% CI 1.00-2.64; p=0.048). Perivalvular complications (HR 1.98, 95% CI 1.19-3.29; p=0.009) were found to be independently associated with mortality in multivariate analysis (HR 1.99, 95% CI 1.05-3.78; p=0.035). One-year survival was 78.3%, whereas three-year ‒ 71.3%. CONCLUSIONS Intrahospital mortality of surgically treated IE patients was 11.2%, however one- and three-year mortality was 21.7 and 28.7%, respectively. Perivalvular complications were independently associated with mortality. Laboratory indices were not predictive of adverse outcomes.